Autopsy report · NCT01281540

An Efficacy and Safety Study of Cisapride in Patients With Chronic Gastroparesis After Failure of Other Treatment Options

“Sponsor request”

The sponsor’s own words in the registry.

Life of this trial

• Registered 7 years 8 months after it had already started.
• Ran for about 6 months before it stopped.
• 20 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Sponsor type

Industry

Conditions

Gastroparesis

Interventions

Cisapride; Placebo

Participants

20

Trials that died the same way

• A Pilot Study of a Micro-Organosphere Drug Screen Platform to Lead Care in Advanced Breast Cancer
  “requested by sponsor” (92% match in meaning)
• A Study to Evaluate ART101 in Adult Participants With Hypertension
  “At Sponsor's Request” (86% match in meaning)
• OTL38 Injection (OTL38) for Intra-Operative Imaging of Folate Receptor Positive Ovarian Cancer
  “Due to sponsor request” (86% match in meaning)
• Cymbalta for Fibromyalgia Pain - Predictive Value of Small Fiber Changed
  “Sponsor related” (81% match in meaning)
• Study of XL228 Administered Intravenously to Subjects With Advanced Malignancies
  “Sponsor decision” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.